Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
申请人:Cai Shaopei
公开号:US20050209247A1
公开(公告)日:2005-09-22
A lacate salt of a compound of Formula I or a tautomer of the compound, wherein Formula I has the following structure and R
1
-R
9
and R
12
-R
14
are as defined herein
PHARMACEUTICALLY ACCEPTABLE SALTS OF QUINOLINONE COMPOUNDS HAVING IMPROVED PHARMACEUTICAL PROPERTIES
申请人:Cai Shaopei
公开号:US20130018058A1
公开(公告)日:2013-01-17
A lacate salt of a compound of Formula I or a tautomer of the compound, wherein Formula I has the following structure and R
1
-R
9
and R
12
-R
14
are as defined herein
一种化合物I的乳酸盐或其互变异构体,其中化合物I具有以下结构,R1-R9和R12-R14如此定义。
Pharmaceutically Acceptable Salts of Quinolinone Compounds Having Improved Pharmaceutical Properties
申请人:Cai Shaopei
公开号:US20130338171A1
公开(公告)日:2013-12-19
A lacate salt of a compound of Formula I or a tautomer of the compound, wherein Formula I has the following structure and R
1
-R
9
and R
12
-R
14
are as defined herein
Advances in site-selective molecular editing have enabled structural modification on complex molecules.
位点选择性分子编辑技术的进步使复杂分子的结构得以改变。
A Pd-Catalyzed one-pot dehydrogenative aromatization and ortho-functionalization sequence of N-acetyl enamides
作者:Jinhee Kim、Youngtaek Moon、Suhyun Lee、Sungwoo Hong
DOI:10.1039/c4cc00027g
日期:——
The one-pot dehydrogenation and ortho-functionalization sequence provides access to highly functionalized arylamine-containing derivatives from readily accessible cyclic N-acetyl enamides.